141 related articles for article (PubMed ID: 8369577)
21. Cyclosporine as maintenance therapy in patients with severe psoriasis.
Shupack J; Abel E; Bauer E; Brown M; Drake L; Freinkel R; Guzzo C; Koo J; Levine N; Lowe N; McDonald C; Margolis D; Stiller M; Wintroub B; Bainbridge C; Evans S; Hilss S; Mietlowski W; Winslow C; Birnbaum JE
J Am Acad Dermatol; 1997 Mar; 36(3 Pt 1):423-32. PubMed ID: 9091474
[TBL] [Abstract][Full Text] [Related]
22. Oral cyclosporin in psoriasis: a systematic review on treatment modalities, risk of kidney toxicity and evidence for use in non-plaque psoriasis.
Maza A; Montaudié H; Sbidian E; Gallini A; Aractingi S; Aubin F; Bachelez H; Cribier B; Joly P; Jullien D; Le Maître M; Misery L; Richard MA; Ortonne JP; Paul C
J Eur Acad Dermatol Venereol; 2011 May; 25 Suppl 2():19-27. PubMed ID: 21388455
[TBL] [Abstract][Full Text] [Related]
23. Long-term efficacy and safety of cyclosporin in severe adult atopic dermatitis.
Berth-Jones J; Graham-Brown RA; Marks R; Camp RD; English JS; Freeman K; Holden CA; Rogers SC; Oliwiecki S; Friedmann PS; Lewis-Jones MS; Archer CB; Adriaans B; Douglas WS; Allen BR
Br J Dermatol; 1997 Jan; 136(1):76-81. PubMed ID: 9039299
[TBL] [Abstract][Full Text] [Related]
24. Life-threatening pustular and erythrodermic psoriasis responding to infliximab.
Lewis TG; Tuchinda C; Lim HW; Wong HK
J Drugs Dermatol; 2006 Jun; 5(6):546-8. PubMed ID: 16774108
[TBL] [Abstract][Full Text] [Related]
25. Treatment of psoriasis with intermittent short course cyclosporin (Neoral). A multicentre study.
Berth-Jones J; Henderson CA; Munro CS; Rogers S; Chalmers RJ; Boffa MJ; Norris PG; Friedmann PS; Graham-Brown RA; Dowd PM; Marks R; Sumner MJ
Br J Dermatol; 1997 Apr; 136(4):527-30. PubMed ID: 9155952
[TBL] [Abstract][Full Text] [Related]
26. Double-blind placebo-controlled study of long-term low-dose cyclosporin in the treatment of palmoplantar pustulosis.
Erkko P; Granlund H; Remitz A; Rosen K; Mobacken H; Lindelöf B; Reitamo S
Br J Dermatol; 1998 Dec; 139(6):997-1004. PubMed ID: 9990362
[TBL] [Abstract][Full Text] [Related]
27. Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: a randomized, open, multicentre assessment of safety and tolerability.
Zachariae H; Abrams B; Bleehen SS; Bräutigam M; Burrows D; Ettelt MJ; Fry L; Happle R; Haustein UF; Ganslandt J; Jung EG; Knop J; Kühne KH; Mellein B; Mørk NJ; Rogers S; Schmidt AG; Schopf RE; Sumner M; Taube KM; Weidinger G; Wurdel C; Zahn E
Dermatology; 1998; 196(2):231-6. PubMed ID: 9568413
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of a fixed-dose cyclosporin microemulsion (100 mg) for the treatment of psoriasis.
Shintani Y; Kaneko N; Furuhashi T; Saito C; Morita A
J Dermatol; 2011 Oct; 38(10):966-72. PubMed ID: 21545506
[TBL] [Abstract][Full Text] [Related]
29. Sequential study on the treatment of moderate-to-severe chronic plaque psoriasis with mycophenolate mofetil and cyclosporin.
Pedraz J; Daudén E; Delgado-Jiménez Y; García-Río I; García-Díez A
J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):702-6. PubMed ID: 16836499
[TBL] [Abstract][Full Text] [Related]
30. Juvenile generalized circinate pustular psoriasis treated with oral cyclosporin A.
Wollina U; Funfstuck V
Eur J Dermatol; 2001; 11(2):117-9. PubMed ID: 11275806
[TBL] [Abstract][Full Text] [Related]
31. Short-term cyclosporin monotherapy for chronic severe plaque-type psoriasis.
Jan V; Vaillant L; Bressieux JM; Barthélemy H; Legoux A; Steiner HG; Reigneau O
Eur J Dermatol; 1999 Dec; 9(8):615-7. PubMed ID: 10586127
[TBL] [Abstract][Full Text] [Related]
32. Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation.
Rosenbach M; Hsu S; Korman NJ; Lebwohl MG; Young M; Bebo BF; Van Voorhees AS;
J Am Acad Dermatol; 2010 Apr; 62(4):655-62. PubMed ID: 19665821
[TBL] [Abstract][Full Text] [Related]
33. Long-term maintenance therapy with cyclosporine and posttreatment survey in severe psoriasis: results of a multicenter study. German Multicenter Study.
Mrowietz U; Färber L; Henneicke-von Zepelin HH; Bachmann H; Welzel D; Christophers E
J Am Acad Dermatol; 1995 Sep; 33(3):470-5. PubMed ID: 7657870
[TBL] [Abstract][Full Text] [Related]
34. Individualized short-course cyclosporin therapy in psoriasis.
Finzi AF
Br J Dermatol; 1996 Sep; 135 Suppl 48():31-4. PubMed ID: 8881902
[TBL] [Abstract][Full Text] [Related]
35. Etretinate in severe psoriasis of children.
Rosińska D; Wolska H; Jablonska S; Konca I
Pediatr Dermatol; 1988 Nov; 5(4):266-72. PubMed ID: 2976495
[TBL] [Abstract][Full Text] [Related]
36. Duration of remission during maintenance cyclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy.
Ellis CN; Fradin MS; Hamilton TA; Voorhees JJ
Arch Dermatol; 1995 Jul; 131(7):791-5. PubMed ID: 7611794
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of cyclosporin with corticotropin for refractory ulcerative colitis.
Okamura S; Aoki H; Ohashi S; Urano F; Shimodaira M; Kanamori S; Ishikawa H; Segawa K
Hepatogastroenterology; 2003; 50(49):91-4. PubMed ID: 12629999
[TBL] [Abstract][Full Text] [Related]
38. Modulation of abnormalities in renal haemodynamics and vasoactive mediators by nifedipine in patients with psoriasis on low-dose cyclosporin.
Edwards BD; Chalmers RJ; O'Driscoll J; Lawson RS; Testa HJ; Ballardie FW
Nephrol Dial Transplant; 1993; 8(10):1071-8. PubMed ID: 8272218
[TBL] [Abstract][Full Text] [Related]
39. Cyclosporin in childhood psoriasis.
Perrett CM; Ilchyshyn A; Berth-Jones J
J Dermatolog Treat; 2003 Jun; 14(2):113-8. PubMed ID: 12775319
[TBL] [Abstract][Full Text] [Related]
40. [Management of severe psoriasis: about 50 cases].
Daoud L; Dhaoui MR; Youssef S; Jaber K; Doss N
Tunis Med; 2007 Oct; 85(10):849-56. PubMed ID: 18236807
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
